News Image

MIRUM PHARMACEUTICALS INC (NASDAQ:MIRM) Screens as a High-Growth Momentum Stock Using Minervini Trend Template

By Mill Chart

Last update: Aug 30, 2025

MIRUM PHARMACEUTICALS INC (NASDAQ:MIRM) has appeared as a notable candidate from a screening method that joins Mark Minervini’s Trend Template with a High Growth Momentum (HGM) rating. This two-part process finds stocks showing both solid technical momentum and strong fundamental growth traits, a key feature of Minervini’s method, which looks for companies in strong uptrends with improving business results. The method focuses on price strength, performance compared to the market, and earnings momentum to find possible leading stocks before significant price gains.

MIRM stock chart

MIRM meets the technical requirements of Minervini’s Trend Template, which is made to find stocks in confirmed uptrends. The present price of $73.87 trades much higher than important moving averages, specifically the 50-day SMA at $57.17, the 150-day SMA at $49.48, and the 200-day SMA at $48.05, with all averages moving up. This arrangement shows continued positive momentum across various periods. Also, the stock is trading within 3% of its 52-week high of $75.74 and is over 100% above its 52-week low of $36.86, showing solid recovery and strength. Its relative strength ranking of 94.56 shows it is performing better than almost 95% of all stocks, an important part of Minervini’s method for finding leading stocks.

From a growth viewpoint, MIRM shows notable fundamental improvement, a main point for investors seeking growth. Revenue growth has been strong, with a trailing twelve-month (TTM) rise of 62.33% and latest quarterly sales growth of 64.09%. The company has exceeded revenue expectations in each of the past four quarters, with an average beat of almost 9%, showing steady operational success. Regarding earnings, while the company is not yet profitable on a net income basis, it shows good progress: EPS growth on a TTM basis is 47.16%, and recent quarterly EPS growth hit 76.92%. Analyst changes have also become positive, with next-year EPS estimates increased by over 19% in the last three months, a positive sign of anticipated future profitability and a typical feature of growth stocks ready for progress.

These growth measures are important within Minervini’s structure because they frequently serve as triggers, attracting institutional attention and supporting more price increases. The mix of strong price trends and fundamental improvement creates a good setting for continued strong performance, especially when the wider market is favorable, as it is now, with the S&P500 showing positive short- and long-term trends.

A look at MIRM’s technical report highlights its strength, with a ChartMill Technical Rating of 9 out of 10, showing very good trend condition and momentum. The stock is in a clear stage 2 uptrend, trading close to new highs with solid performance compared to its industry. However, the setup rating is average at 3, indicating that while the stock is technically healthy, it may not now present a perfect low-risk entry chance because of recent price changes and extended movement. For a complete review, readers can see the full technical report here.

Investors wanting to find other growth-oriented, technically solid candidates can use the predefined screen that found MIRM. This screen joins Minervini’s trend standards with strict growth filters, helping users quickly find possible opportunities. Click here to access the screen and view more results.

Disclaimer: This is not investment advice. This article is for informational and educational purposes only. All investment decisions should be made based on your own research, risk tolerance, and financial circumstances. Please read our full disclaimer here.

MIRUM PHARMACEUTICALS INC

NASDAQ:MIRM (8/29/2025, 8:00:01 PM)

After market: 73.87 0 (0%)

73.87

-1.66 (-2.2%)



Find more stocks in the Stock Screener

MIRM Latest News and Analysis

Follow ChartMill for more